Bioequivalence Studies: What the FDA Requires Manufacturers to Prove
The FDA requires generic drug manufacturers to prove bioequivalence through rigorous human studies showing their product absorbs at the same rate and extent as the brand-name drug. This ensures safety and effectiveness.